Celestia Diagnostics
Birmingham
About Celestia Diagnostics
Celestia Diagnostics is a healthcare company that focuses on the development of diagnostic tests for infection-associated chronic conditions. One of their key projects is the creation of a blood test for the diagnosis of Long COVID, using amyloid microthrombi and platelet pathologies. This innovative approach to diagnostics aims to provide a more accurate and efficient method of identifying and managing chronic conditions associated with infections.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $375.0K
- Funding stage: Seed
- Last round: Grant (Jun 2024)
- Website: celestiadiagnostics.com
Industries & Categories
Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/celestia-diagnostics-25023 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.